Literature DB >> 11222825

Sarcoidosis 2001.

D G James1.   

Abstract

In every decade, sarcoidosis makes a chameleon-like change so its profile needs to be updated. It was first recognised as a dermatological curiosity which evolved into a multisystem disorder with bone cysts, uveitis, and intrathoracic involvement. New dimensions were uncovered by biochemistry and immunology, bringing it still nearer the elusive enigma, namely the cause of sarcoidosis. Aetiology includes an understanding of a genetic predisposition and environmental trigger factors. What was left undone in the 20th century will become evident in the 21st century with more sophisticated technology. Likewise, conventional treatments of the past will be superseded by cytokines and other magic bullets of the millennium.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11222825      PMCID: PMC1741943          DOI: 10.1136/pmj.77.905.177

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  15 in total

Review 1.  Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases.

Authors:  H Reiser; M J Stadecker
Journal:  N Engl J Med       Date:  1996-10-31       Impact factor: 91.245

2.  Inter-relationship between tumour necrosis factor-alpha (TNF-alpha) and TNF soluble receptors in pulmonary sarcoidosis.

Authors:  L Armstrong; N M Foley; A B Millar
Journal:  Thorax       Date:  1999-06       Impact factor: 9.139

3.  Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study.

Authors:  G Raghu; W C Johnson; D Lockhart; Y Mageto
Journal:  Am J Respir Crit Care Med       Date:  1999-04       Impact factor: 21.405

4.  Correlation of CD4:CD8 ratio and tumour necrosis factor (TNF)alpha levels in induced sputum with bronchoalveolar lavage fluid in pulmonary sarcoidosis.

Authors:  Y P Moodley; T Dorasamy; S Venketasamy; V Naicker; U G Lalloo
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

5.  Expression of RANTES by bronchoalveolar lavage cells in nonsmoking patients with interstitial lung diseases.

Authors:  N Kodama; E Yamaguchi; N Hizawa; K Furuya; J Kojima; M Oguri; T Takahashi; Y Kawakami
Journal:  Am J Respir Cell Mol Biol       Date:  1998-04       Impact factor: 6.914

6.  Correlation of plasma monocyte chemoattractant protein-1 (MCP-1) and monocyte inflammatory protein-1alpha (MIP-1alpha) levels with disease activity and clinical course of sarcoidosis.

Authors:  S Hashimoto; T Nakayama; Y Gon; N Hata; T Koura; S Maruoka; K Matsumoto; S Hayashi; Y Abe; T Horie
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

7.  Association between angiotensin II receptor gene polymorphism and serum angiotensin converting enzyme (SACE) activity in patients with sarcoidosis.

Authors:  Y Takemoto; M Sakatani; S Takami; T Tachibana; J Higaki; T Ogihara; T Miki; T Katsuya; T Tsuchiyama; A Yoshida; H Yu; Y Tanio; E Ueda
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

8.  The distribution of lymphoid and macrophage like cell subsets of sarcoid and Kveim granulomata: possible mechanism of negative PPD reaction in sarcoidosis.

Authors:  B B Mishra; L W Poulter; G Janossy; D G James
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

9.  Measurement of serum monocyte chemoattractant protein-1 and its clinical application for estimating the activity of granuloma formation in sarcoidosis.

Authors:  K Iyonaga; M Suga; H Ichiyasu; T Yamamoto; Y Hiraga; M Ando
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  1998-09       Impact factor: 0.670

10.  The sarcoidosis movement and its personalities.

Authors:  D G James
Journal:  J Med Biogr       Date:  1995-08
View more
  7 in total

Review 1.  Practical issues and challenges in the diagnosis and treatment of pulmonary sarcoidosis.

Authors:  Surinder K Jindal
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Sarcoidosis in black women in the United States: data from the Black Women's Health Study.

Authors:  Yvette C Cozier; Jeffrey S Berman; Julie R Palmer; Deborah A Boggs; David M Serlin; Lynn Rosenberg
Journal:  Chest       Date:  2010-07-01       Impact factor: 9.410

3.  Unsuspected Active Sarcoidosis Diagnosed by 18F-FDG PET/CT During the Search for a Primary Tumour in a Patient with Bone Lesions.

Authors:  Federico Caobelli; Sara Vincenzina Gabanelli; Antonio Brucato; Claudio Pizzocaro; Alberto Soffientini; Raffaele Giubbini; Ugo Paolo Guerra
Journal:  Nucl Med Mol Imaging       Date:  2013-04-24

4.  Spontaneous resolution of systemic sarcoidosis in a patient with chronic hepatitis C without interferon therapy.

Authors:  Tae-Hun Kim; Jong-Eun Joo
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

5.  A single photon emission computed tomography of the chest with the use of receptor radiotracer (Tc-99m-Depreotide) in sarcoidosis.

Authors:  Stanisław Pilecki; Roman Junik; Marcin Gierach; Joanna Gierach; Grzegorz Przybylski; Agnieszka Jarzemska; Władysław Lasek
Journal:  Pol J Radiol       Date:  2010-01

Review 6.  Celiac disease and autoimmune-associated conditions.

Authors:  Eugenia Lauret; Luis Rodrigo
Journal:  Biomed Res Int       Date:  2013-07-24       Impact factor: 3.411

7.  Imaging Findings in Sarcoid of the Humerus.

Authors:  Sidhartha Chaudhry; Michael L Richardson
Journal:  Radiol Case Rep       Date:  2015-12-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.